David Reese

Amylyx Pharmaceuticals

Camille Bedrosian

Amylyx Pharmaceuticals has appointed Camille Bedrosian as chief medical officer. Bedrosian has nearly three decades of experience addressing unmet medical needs in areas of rare and serious diseases. She most recently served as strategic development advisor at Ultragenyx, following her position as chief medical officer and executive vice president. Bedrosian previously held senior positions at Alexion and ARIAD.

AC Immune

Madiha Derouazi

AC Immune has appointed Madiha Derouazi as chief scientific officer. Derouazi brings to her new role over a decade of experience in senior positions across multiple specialty areas, including antigen delivery, cancer vaccines and anti-tumour immunity. She most recently served as chief executive officer at Speransa Therapeutics. Prior to this, Derouazi held the position of chief executive officer at Amal Therapeutics.

Kling Bio

Stefano Gullà

Kling Bio has appointed Stefano Gullà as chief scientific officer. Gullà brings over a decade of experience in biotherapeutics discovery and development to his new position. He most recently served as vice president, biology and head of protein therapeutics at RVAC Medicines. He also previously served as senior director of pharmacology and preclinical development at Repertoire Immune Medicines.

PrecisionLife

Gerald Dunstan

PrecisionLife has appointed Gerald Dunstan as senior vice president, corporate development. Dunstan holds over two decades of experience in commercial roles for biopharma companies, healthcare providers and payers. He most recently served as chief strategy officer at Prescient Healthcare Group, which followed his position as partner at GE Healthcare Partners. He has also held senior positions for Medtronic and KPMG UK.

Asceneuron

Abbas Hussain

Asceneuron has appointed Abbas Hussain as chair to its board of directors. Hussain has over 35 years of experience in the healthcare industry and has held a range of senior leadership positions, including as president of global pharmaceuticals at GSK. He was also previously president of Europe at Eli Lilly and chief executive officer of Vifor Pharma.

Versameb

Alexandre LeBeaut

Versameb has appointed Alexandre LeBeaut as chair of the board of directors. LeBeaut has over two decades of global research and development experience across areas, including immunology, oncology, gastroenterology, cardio-metabolic and infectious diseases. He currently serves as an independent director of OSE Immunotherapeutics. LeBeaut also serves as an independent board member for ImmunoRx Pharma and Calypso Biotech.

Akiram Therapeutics

Anna Törner

Akiram Therapeutics has appointed Anna Törner to its board of directors. Törner, who is the founder of SDS Life Science and SDS MedteQ, has extensive experience in drug development, with a special focus on regulatory affairs and statistics. She is currently active as a consultant, specialising in these areas, and also she serves on the boards of several companies, including Respiratorius and MedCap.

PrecisionLife

Hannah Bibby

PrecisionLife has appointed Hannah Bibby as product strategy lead. Bibby has a wealth of experience in life sciences consulting within digital health, medtech and pharmaceuticals. She most recently served as part of Owkin’s diagnostics product strategy team. Prior to this, she served as life sciences consultant at LEK Consulting, following her role as life sciences senior associate consultant at the company.